Investigation of computed tomography findings of portal hypertension at non-alcoholic fatty liver disease

被引:0
|
作者
Kulali, Fatma [1 ]
Kaya-Tuna, Burcu [1 ]
Semiz-Oysu, Aslihan [1 ]
Kilicoglu, Zeynep Gamze [2 ]
Bukte, Yasar [1 ]
机构
[1] Umraniye Training & Res Hosp, Istanbul, Turkey
[2] Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey
关键词
Hepatosteatosis; Portal hypertension; Fatty liver; Cirrhosis;
D O I
10.1016/j.ejrnm.2016.05.012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) is very common and serious disease. It begins as a simple hepatosteatosis but can progress to cirrhosis. The early detection of portal hypertension (HT) can be helpful in the management of these patients. Aims: To evaluate radiologic findings of portal hypertension at computed tomography (CT) of patients with non-alcoholic fatty liver disease for early diagnosis. Methods and materials: Images of 225 cases who underwent non-enhanced abdominal CT were reviewed. The patients with the difference between hepatic and splenic attenuation (CT L-S) > 10 were enrolled in hepatosteatosis group. The remainings formed control group. The relationship between two groups about diameters of portal and splenic veins, craniocaudal (CC) span of liver, splenic index, caudate lobe/right lobe (C/RL) ratio was analyzed statistically by Mann-Whitney U Test and Student's t-test. Results: Total 213 cases, as hepatosteatosis (n = 149) and control (n = 64) groups, were involved in this study. Liver CC span, splenic index and C/RL ratio between two groups were found to be statistically significant (p < 0.01). Conclusions: The splenic index and C/RL ratio are important findings of portal HT and fibrosis. CT imaging can be beneficial for diagnosis and treatment of NAFLD patients. (C) 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [11] Burden of non-alcoholic fatty liver disease in Australia
    Mahady, Suzanne E.
    Adams, Leon A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 1 - 11
  • [12] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [13] Non-alcoholic fatty liver disease in 2015
    Ahmed, Monjur
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (11) : 1450 - 1459
  • [14] Non-alcoholic fatty liver disease: An overview
    Mulhall, BP
    Ong, JP
    Younossi, ZM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (11) : 1136 - 1143
  • [15] Carotenoids and non-alcoholic fatty liver disease
    Yilmaz, Bahiddin
    Sahin, Kazim
    Bilen, Hande
    Bahcecioglu, Ibrahim H.
    Bilir, Birdal
    Ashraf, Sara
    Halazun, Karim J.
    Kucuk, Omer
    HEPATOBILIARY SURGERY AND NUTRITION, 2015, 4 (03) : 161 - 171
  • [16] Treatment of non-alcoholic fatty liver disease
    Takei, Yoshiyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 79 - 80
  • [17] Pathology of non-alcoholic fatty liver disease
    Cataldo, Ivana
    Sarcognato, Samantha
    Sacchi, Diana
    Cacciatore, Matilde
    Baciorri, Francesca
    Mangia, Alessandra
    Cazzagon, Nora
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 194 - 202
  • [18] Hypogonadism and non-alcoholic fatty liver disease
    Mintziori, Gesthimani
    Poulakos, Pavlos
    Tsametis, Christos
    Goulis, Dimitrios G.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 145 - 150
  • [19] Iron and non-alcoholic fatty liver disease
    Britton, Laurence J.
    Subramaniam, V. Nathan
    Crawford, Darrell H. G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8112 - 8122
  • [20] Pediatric Non-alcoholic Fatty Liver Disease
    Uppal V.
    Mansoor S.
    Furuya K.N.
    Current Gastroenterology Reports, 2016, 18 (5)